Navigation Links
Nutrastar Announces Full Year 2012 Results, Issues 2013 Revenue Guidance
Date:3/29/2013

HARBIN, China, March 29, 2013 /PRNewswire-FirstCall/ -- Nutrastar International Inc. (OTCBB: NUIN; "Nutrastar" or the "Company"), a leading producer and supplier of premium branded consumer products, including commercially cultivated Cordyceps Militaris ("Cordyceps"), functional health beverages and organic and specialty foods, today announced its results for the year ended December 31, 2012.

Financial Highlights 
 

  • Net revenue was $36.77 million, an increase of 7.5% from full year 2011.
  • Gross profit was $28.03 million, representing a gross margin of 76.2%, an increase of 0.3% from the previous year.
  • Net income was $17.24 million, representing a net margin of 46.9%.
  • Basic and diluted EPS were $1.10 and $1.04, respectively, with 15.45 million basic shares and 16.60 million diluted shares outstanding.

  • Management Commentary

    "While we were quite pleased with our 2012 financial results, as mentioned last quarter, the Company experienced a supply shortage due to required operational maintenance that occurred within our facilities – resulting in full year sales being lower than expected. Despite this short disruption, total sales for the year ended December 31, 2012 grew by 7.5% reaching approximately $36.8 million, as compared to the previous year's sales of $34.2 million. High demand led to a 9.5% year-over-year increase in sales of our core consumer product, Cordyceps; while organic specialty foods sales saw a 4.7% increase and functional health beverages saw a 0.9% increase. Gross profit remained strong at 76.2%. The year of 2012 was also marked by the completion of our large multi-phase, multi-year production capacity expansion project, which overall boosted capacity from 55 tons to 100 tons, a huge milestone achieved for the Company and the team," Ms. Lianyun Han, CEO of Nutrastar, commented.

    On the subject of the Company's finan
    '/>"/>

    SOURCE Nutrastar International Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Nutrastar International Completes Multi-Year Production Expansion Project Bringing Cordyceps Capacity to 100 Tons
    2. International Isotopes Inc. Announces 2012 Year End Financial Results
    3. Omeros Announces Toxicology Data that Support Advancing MASP-2 Inhibitor into Clinical Trials
    4. ShangPharma Corporation Announces Completion of Merger
    5. ReSearch Pharmaceutical Services Announces Joint Venture with Asklep in Japan
    6. Convergence Pharmaceuticals Announces Successful Interim Data from Ground-Breaking Phase II Trigeminal Neuralgia Study
    7. CleanPath Resources Corp Announces Worldwide Exclusive Stem Cell Enhancement Agreement with a Division of Hemp, Inc.
    8. Neurocrine Biosciences Announces the Start of Phase IIb Study of Elagolix in Uterine Fibroids
    9. Breckenridge announces agreement with Aptalis Pharmatech to market Propranolol Hydrochloride Extended-Release Capsules
    10. TriReme Announces Signing of a Master Distribution Agreement in China
    11. Genalyte Announces CE Mark For Maverick(TM) Detection System And Signs On First European Distributors
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/27/2015)... -- Una presentazione speciale durante la settimana della prevenzione ... di MERG valutare i successi ottenuti grazie all,adozione ... popolazioni di pazienti affetti dalla patologia. ... Fass , MD della Case Western Reserve University, ha ... alla terapia Stretta. Un panel di esperti ha quindi ...
    (Date:5/27/2015)... -- Biosensors International Group, Ltd. ("Biosensors " or the ... developer, manufacturer and marketer of innovative medical devices, today ... FY15") and fiscal full year ended 31 March 2015 ... , Q4 FY15: , Total revenue of ... Fiscal Year 2014 ("Q4 FY14") due to licensing revenue ...
    (Date:5/27/2015)... , May 27, 2015  PDL BioPharma, Inc. ... John P. McLaughlin , the company,s president and chief ... Healthcare Conference next week in New York City.  The ... June 3, 2015 at 11:30 a.m. EDT. ... the presentation, go to the Company,s website at ...
    Breaking Medicine Technology:Alla Settimana delle malattie digestive, la terapia Stretta è stata presentata come un trattamento versatile ed efficace per svariate popolazioni di pazienti affetti dalla patologia MERG 2Alla Settimana delle malattie digestive, la terapia Stretta è stata presentata come un trattamento versatile ed efficace per svariate popolazioni di pazienti affetti dalla patologia MERG 3Alla Settimana delle malattie digestive, la terapia Stretta è stata presentata come un trattamento versatile ed efficace per svariate popolazioni di pazienti affetti dalla patologia MERG 4Biosensors Reports Financial Results for Fiscal Year 2015 2Biosensors Reports Financial Results for Fiscal Year 2015 3Biosensors Reports Financial Results for Fiscal Year 2015 4Biosensors Reports Financial Results for Fiscal Year 2015 5Biosensors Reports Financial Results for Fiscal Year 2015 6Biosensors Reports Financial Results for Fiscal Year 2015 7PDL BioPharma to Present at Jefferies 2015 Global Healthcare Conference 2
    ... TRIANGLE PARK, N.C., Jan. 6, 2011 CeNeRx BioPharma, Inc., today ... new formulation of TriRima ™, the company,s novel antidepressant in ... it will be presenting at Biotech Showcase™ ... 11:00 AM PST. TriRima is a member ...
    ... Pharmasset, Inc. (Nasdaq: VRUS ), announced today positive ... HCV genotype 2 or 3 (GT2/3) arm of the PSI-7977 Phase ... dual nucleotide study.   Pipeline Update and ... PSI-7977 in combination with pegylated interferon and ribavirin (Peg-IFN/RBV) in a ...
    Cached Medicine Technology:CeNeRx Initiates Phase II Trial of TriRima™ as Monotherapy in Treatment Resistant Depression 2CeNeRx Initiates Phase II Trial of TriRima™ as Monotherapy in Treatment Resistant Depression 3Pharmasset Reports Positive Results from its HCV Clinical Programs 2Pharmasset Reports Positive Results from its HCV Clinical Programs 3Pharmasset Reports Positive Results from its HCV Clinical Programs 4Pharmasset Reports Positive Results from its HCV Clinical Programs 5Pharmasset Reports Positive Results from its HCV Clinical Programs 6
    (Date:5/27/2015)... SAN DIEGO, May 27, 2015 ... the first healthcare provider along the Gulf Coast ... management (CCM). In partnership with MD Revolution, a ... a new program that enables healthcare providers to ... reimbursements. This new, user-friendly program is designed to ...
    (Date:5/27/2015)... May 27, 2015 CompanionDx ... and somatic genomic analysis in personalized cancer therapy: Non-small ... the American Society of Clinical Oncology (ASCO) as part ... in Chicago. , The molecular and clinical data used ... Atlas (TCGA) database. The study reports improved patient outcomes ...
    (Date:5/27/2015)... (PRWEB) May 27, 2015 On June ... advertising agency, will partner with LifeSource to host Donate ... will take place in a LifeSource donor coach outside ... to 4:00 p.m. , Demand for whole blood units ... Illinois, during the summer months. LifeSource requires approximately 1,000 ...
    (Date:5/27/2015)... Dallas, Texas (PRWEB) May 27, 2015 ... on the current state of the Omega-3 industry. ... industry including definitions, classifications, applications and industry chain ... the international markets including development trends, competitive landscape ... Products, Gc Rieber Oils, Camanchaca Fishing Company, Seadragon ...
    (Date:5/27/2015)... 2015 SonarMD, LLC, recently ... a first-of-its kind, cloud-based algorithmic process for ... chronic gastrointestinal disease. , Developed by noted ... allows physicians to monitor their patients’ health ... of electronic health assessment surveys. Using nationally ...
    Breaking Medicine News(10 mins):Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 2Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 3Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 2Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 3Health News:Donate Your Break and Save Lives at the River North Blood Drive 2Health News:Omega-3 Market: Global 2015 Analysis & 2020 Forecasts on Market Size 2Health News:SonarMD™, LLC, Launches Game-Changing, IBD Population Health Management Platform 2
    ... West Indies cricket captain Brian Lara has thrown a punch ... opening of a cancer center named after him. ... and management of the Brian Lara Cancer Center for their ... "missed" the (West Indies) the Cricket Board. ,His ...
    ... people with celiac disease are waiting an average of 13 ... gut disorder caused by gluten intolerance, and can lead to ... is a protein group found in wheat and other flours ... the carbon dioxide (CO2) produced by the yeast and expands ...
    ... all the wrong reasons. ,Civic authorities ... who use the Hudson River of the potential health problems ... the river after a main broke Friday afternoon. ... in contact with the sewage and ingesting bacteria that could ...
    ... the seizure drug valporate, which is marketed by Abbott ... their risk of having an infant with mental ... annual meeting of the American Academy of Neurology in ... Meador, professor of neurology at the University of Florida, ...
    ... underwent a simultaneous liver and kidney transplant at a ... claimed as the first such in the world. ... as primary Hyperoxaluria, in which the liver lacks an ... bones, heart and pancreas. Patients suffering from the disease ...
    ... who are on estrogen therapy before the age of 65. ... risk of Alzheimers disease or dementia. ,The study showed ... the age of 65 cut their risk of dementia by 50%, ... the age of 65. ,This study was part ...
    Cached Medicine News:Health News:Gluten Intolerance Cases Diagnosed Late in UK 2Health News:Sewage Flows into Hudson River in a Torrent 2Health News:Sewage Flows into Hudson River in a Torrent 3Health News:NRI Boy Underwent a Rare Dual Transplant Surgery 2
    Inquire...
    ... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
    ... A fixed pipette is ... a single volume. Fixed volume ... and advantages as other Finnpipette ... design, Super blow-out (1-40ul), Soft-touch ...
    500L...
    Medicine Products: